以9月5日收盘价计算，京东健康目前市盈率（TTM）约39.49倍，市净率（TTM）约3.22倍，市销率（TTM）约2.86倍。 市净率(LF)历史分位(%) 001 900 82 49 80 70 68x29 60 52025 50 47d02 40 x0.6 39d 4 30 20 15×31 10 2.41 0 -30 2n- 制图数据来自恒生聚源数据库 公司主要从事"互联网+医疗健康"生态系统业务，主要为客户提供医药和健康产品、互联网医疗、健康管理及智能医疗保健解决方案及为业务合作伙伴提供 市场营销服务。主要在国内市场开展业务。 历年营收、净利同比增长情况(%) 京东健康2024年营业收入构成(亿元) 服务 爱 93.642 商品收入-医药 和健康产品销售 487.9 商品收入-医药和健康产品销售 服务收入-平台、广告及其他服务 制图数据来自恒生聚源数据库 历年人均创利/创收情况(万元) 1,800 - 1740.89 1723.02 1500 1,200 900 600 300 0 - T T 2020 2021 2022 2023 -○- 人均创收 -○- 人均创利 制图数据来自恒生聚源数据库 20 ...

Group 1 - The core point of the article is that Guo En Holdings (stock code: 8121) announced a new share placement to raise approximately HKD 30 million, with net proceeds expected to be around HKD 27 million after expenses [1] - The placement involves issuing up to 5,000,000 new shares at a price of HKD 0.60 per share, which represents an 11.8% discount compared to the previous closing price of HKD 0.68 [1] - The new shares will account for approximately 20.0% of the existing issued share capital and about 16.7% of the enlarged share capital after the placement [1] Group 2 - The funds raised will primarily support the development of the company's healthcare business, including hiring talent, covering daily expenses, conducting marketing activities, and developing sales platforms [1] - The placement is conducted under a general mandate granted by the shareholders' meeting and is expected to be completed within five business days after the fulfillment of the placement agreement's conditions [1]